National and Kapodistrian University of Athens
Μελέτη του παθογενετικού ρόλου της κυτταροκίνης RANKL σε διαγονιδιακά ζωικά πρότυπα
Abstract
dc:descriptionReceptor activator of NF-κBligand (RANKL) plays a key role in osteoclast-induced bone resorption across a range of degenerative bone diseases, and its specific inhibition has been recently approved as a treatment for women with postmenopausal osteoporosis at high or increased risk of fracture. In the present study, we generated transgenic mice (TghuRANKL) carrying the human RANKL (huRANKL) genomic region and achieved a physiologically relevant pattern of RANKLoverexpression in order to establish novel genetic models for assessing skeletal pathologies associated with excessive RANKL and for testing clinical therapeutic candidates that inhibit human RANKL. TghuRANKL mice of both sexes developed early onset bone loss, and the levels of huRANKL expression were correlated with bone resorption and disease severity. Low copy Tg5516 mice expressing huRANKL at low levels displayed a mild osteoporotic phenotype as shown by trabecular bone loss. Notably, overexpression of huRANKL, in the medium copy Tg5519 line, resulted in severe early-onset osteoporosis characterized by lack of trabecular bone, ditsruction of the growth plate, increased osteocalstogenesis, bone marrow adiposity, increased bone remodeling and severe cortical bone porosity accompanied by decreased bone strength. An even more severe skeletal phenotype developed in the high copy Tg5520 founder with extensive soft tissue calcification. Notably, the osteopetroticphenotype of mutant mice expressing an inactiveform of the endogenous RANKL proteinwasrescueduponcrossingthese mice with TghuRANKL mice, showingthat the transgenic human RANKL proteinisfullyactive in the mouse. Alendronate at the dose of 1mg/Kg was administrered subcutaneously in the low-copy Tg5516 mice once a week. Our results confirmed that alendronate fully restored the osteoporotic trabecular stucture in Tg5516 mice that exhibits a mild phenotype.These novel huRANKL transgenic models of osteoporosis represent an important advance for understanding the pathogenesis and treatment of high- turnover bone diseases and other disease states caused by excessive RANKL.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Niti, Alexandra
- Νίτη, Αλεξάνδρα
Subjects
dc:subject × 10Rights
dc:rights- Statement dc:rights
-
- BY_ND
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/36287